Parkinsonism and rabbit syndrome after discontinuation of low-dose ziprasidone and concomitant initiation of sertraline

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 142-143

  Gray, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE; LAMOTRIGINE; LITHIUM; QUETIAPINE; SERTRALINE; ZIPRASIDONE;

ADULT; BIPOLAR DISORDER; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEPRESSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; PARKINSONISM; PRIORITY JOURNAL; RABBIT SYNDROME; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; ISOXAZOLES; PYRIMIDINES;

EID: 84855410510     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823f912a     Document Type: Letter

References (20)

1. Schmidt AW, Lebel LA, Howard HR, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol. 2001;425: 197-201. (Pubitemid 32770067)
2. Mamo D, Kapur S, Shammi CM, et al. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Am J Psychiatry. 2004;161:818-825. (Pubitemid 38625334)
3. Keck P, Buffenstein A, Ferguson J, et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacology (Berl). 1998;140:173-184. (Pubitemid 28538477)
4. Mason MN, Johnson CE, Piasecki M. Ziprasidone-induced acute dystonia. Am J Psychiatry. 2005;162:625-626.
5. Bilal L, Tsai C, Gasper JJ, et al. Parkinsonism with intramuscular ziprasidone. Am J Psychiatry. 2005;162:2392-2393.
6. Ramos AE, Shytle RD, Silver AA, et al. Ziprasidone induced oculogyric crisis. J Am Acad Child Adolesc Psychiatry. 2003;42:1013-1014.
7. Ananth J, Burgoyne KS, Niz D, et al. Tardive dyskinesia in 2 patients treated with ziprasidone. J Psychiatry Neurosci. 2004;29:467-469. (Pubitemid 40075718)
8. Keck ME, Muller MB, Binder EB, et al. Ziprasidone-related tardive dyskinesia. Am J Psychiatry. 2004;161:175-176.
9. Oral ET, Altinbas K, Demirkiran S. Sudden akathisia after a ziprasidone dose reduction. Am J Psychiatry. 2006;163:546. (Pubitemid 44469404)
10. Villeneuve A. The rabbit syndrome. A peculiar extrapyramidal reaction. Can Psychiatr Assoc J. 1972;17(suppl 2):SS69.
11. Jus K, Villeneuve A, Jus A. Tardive dyskinesia and the rabbit syndrome during wakefulness and sleep. Am J Psychiatry. 1972;129:765.
12. Wu CC, Su KP. Quetiapine-induced rabbit syndrome in a patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:2002-2003.
13. Teng PR, Lai TJ. Paliperidone-related rabbit syndrome. J Clin Psychopharmacol. 2011;31:379-380.
14. Nishimura K, Tsuka M, Horikawa N. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone. Eur Neuropsychopharmacol. 2001;11:323-324. (Pubitemid 32781012)
15. Parvin MM, Swartz CM. Dystonic rabbit syndrome from citalopram. Clin Neuropharmacol. 2005;28: 289-291. (Pubitemid 44378621)
16. Wada Y, Yamaguchi N. The rabbit syndrome and antiparkinsonian medication in schizophrenic patients. Neuropsychobiology. 1992;25:149-152.
17. Jus K, Jus A, Gautier J, et al. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome. Int J Clin Pharmacol. 1974;9:138-145.
18. Casey DE. Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes. Psychopharmacol Ser. 1993;10:101-110.
19. Dixon L, Thaker G, Conley R, et al. Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. Schizophr Res. 1993;10:267-271. (Pubitemid 23353442)
20. Madhusoodanan S, Alexeenko L, Sanders R, et al. Extrapyramidal symptoms associated with antidepressants: a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatr. 2010;22:148-156.